| # | Drug | Count |
|---|---|---|
| 0 | INFLIXIMAB | 12 |
| 1 | VEDOLIZUMAB | 12 |
| 2 | ADALIMUMAB | 11 |
| 3 | ADALIMUMAB-AATY | 11 |
| 4 | ADALIMUMAB-ADAZ | 11 |
| 5 | ADALIMUMAB-FKJP | 11 |
| 6 | AZATHIOPRINE | 11 |
| 7 | GOLIMUMAB | 11 |
| 8 | MESALAMINE | 11 |
| 9 | RITUXIMAB | 11 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | PURIXAN | 1 | 0.0013 |
| 1 | FLUTAMIDE | 1 | 0.0010 |
| 2 | GOLIMUMAB | 11 | 0.0009 |
| 3 | TOFACITINIB CITRATE | 11 | 0.0008 |
| 4 | CLOMIPHENE CITRATE | 1 | 0.0007 |
| 5 | MERCAPTOPURINE | 10 | 0.0006 |
| 6 | MESALAMINE | 11 | 0.0004 |
| 7 | ADALIMUMAB-FKJP | 11 | 0.0002 |
| 8 | ADALIMUMAB-AATY | 11 | 0.0002 |
| 9 | ADALIMUMAB-ADAZ | 11 | 0.0002 |
| # | Drug class | Count |
|---|---|---|
| 0 | Tumor Necrosis Factor Blocker [EPC] | 14 |
| 1 | Integrin Receptor Antagonist [EPC] | 12 |
| 2 | Aminosalicylate [EPC] | 11 |
| 3 | CD20-directed Cytolytic Antibody [EPC] | 11 |
| 4 | Interleukin-12 Antagonist [EPC] | 11 |
| 5 | Interleukin-23 Antagonist [EPC] | 11 |
| 6 | Janus Kinase Inhibitor [EPC] | 11 |
| 7 | Purine Antimetabolite [EPC] | 11 |
| 8 | Corticosteroid [EPC] | 6 |
| 9 | Benzodiazepine [EPC] | 2 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Integrin Receptor Antagonist [EPC] | 12 | 0.0001 |
| 1 | Purine Antimetabolite [EPC] | 11 | 0.0001 |
| 2 | Aminosalicylate [EPC] | 11 | 0.0001 |
| 3 | Interleukin-12 Antagonist [EPC] | 11 | 0.0001 |
| 4 | Interleukin-23 Antagonist [EPC] | 11 | 0.0001 |
| 5 | Sulfone [EPC] | 1 | 0.0001 |
| 6 | Janus Kinase Inhibitor [EPC] | 11 | 0.0001 |
| 7 | CD20-directed Cytolytic Antibody [EPC] | 11 | 0.0000 |
| 8 | Estrogen Receptor Antagonist [EPC] | 1 | 0.0000 |
| 9 | Calcineurin Inhibitor Immunosuppressant [EPC] | 2 | 0.0000 |